Horizon Pharma, Inc. (HZNP) to Present at the 11th Annual Biotechnology Industry Organization (BIO) Investor Forum  
9/27/2012 8:52:21 AM

DEERFIELD, IL--(Marketwire - September 27, 2012) - Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Todd Smith, executive vice president and chief commercial officer, will present at the 11th Annual BIO Investor Forum on Tuesday, October 9, 2012 at 4:30 p.m. Pacific Time (7:30 p.m. Eastern Time) in San Francisco, CA. Mr. Smith will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit

Robert J. De Vaere
Executive Vice President and Chief Financial Officer
Email Contact

Geoff Curtis
DJE Science
Email Contact

Kathy Galante
Burns McClellan, Inc.
Email Contact